Key result
Standardized BP ≥140/90 mmHg predicts ~111% greater CVD risk, outperforming routine measurements.
Why the study?
Do standardized blood pressure measurements provide a stronger association with cardiovascular disease risk compared to routine measurements in middle-aged individuals?
Cohort (n=19,720)
Do standardized blood pressure measurements provide a stronger association with cardiovascular disease risk compared to routine measurements in middle-aged individuals?
Hazard Ratio: 2.11 (95% CI 1.77–2.51)
Routine blood pressure measurements in primary care overestimate BP and attenuate the association with cardiovascular disease risk compared to standardized measurements, highlighting the critical need for accurate BP measurement protocols.
Routine BP overestimates hypertension and weakens CVD associations versus standardized readings; leaves open whether protocol standardization improves risk stratification.
BACKGROUND: Recommendations for blood pressure (BP) measurement are poorly followed in clinical practice, possibly leading to inaccurate BP estimates. OBJECTIVES: To assess the agreement between routine and standardized BPs, and the association between BP level and cardiovascular disease (CVD) for each measurement type. METHODS: Standardized BPs were recorded in a screening program for middle-aged people during 1992-2012 in Sweden. Intraindividual differences between standardized BP and routine BP from primary care were calculated. Association between BP level and composite CVD, and population-attributable fraction (PAF) explained by BP, were determined through adjusted Cox regression for each measurement type. RESULTS: In 9567 participants, routine BPs were on average 4.0/1.7 mmHg higher than standardized BPs. Routine measurements frequently misclassified people into higher BP categories; 16% more had hypertension (≥130/80 mmHg), and 50% less had normal BP (<120/80 mmHg), compared with standardized measurements. Analysis of 19,720 participants found a stronger association between BP level and CVD for standardized than for routine measurements, with increased risk from ≥120/80 and ≥140/90 mmHg, respectively. Adjusted hazard ratio for ≥140/90 mmHg compared to <120/80 mmHg was 2.11 (95% confidence interval 1.77-2.51) for standardized BPs and 1.43 (1.15-1.77) for routine BPs. BP ≥120/80 mmHg explained 41.8% (32.0-50.1) of CVD events with standardized measurements and 19.3% (1.5-33.8) with routine measurements. CONCLUSION: Routine BPs deviate from standardized BPs, resulting in significant misclassification and attenuated association with CVD, reducing the PAF for BP to less than half. Our findings emphasize the need for accurate BP measurement in clinical practice.
No takes yet. Share an insight, caveat, or question.
Gästgivars et al. (2026) reported a cohort. Standardized blood pressure measurements vs. Routine blood pressure measurements was evaluated on Composite cardiovascular disease (CVD) (HR 2.11, 95% CI 1.77-2.51). Standardized blood pressure ≥140/90 mmHg was more strongly associated with cardiovascular disease (HR 2.11; 95% CI 1.77-2.51) than routine measurements (HR 1.43; 95% CI 1.15-1.77).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: